Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
Authors
Keywords
-
Journal
Frontiers in Bioengineering and Biotechnology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-12-17
DOI
10.3389/fbioe.2019.00406
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adapting Proteostasis and Autophagy for Controlling the Pathogenesis of Cystic Fibrosis Lung Disease
- (2019) Manish Bodas et al. Frontiers in Pharmacology
- Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
- (2019) Iwona Pranke et al. Frontiers in Pharmacology
- Self-assembled peptide–poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis
- (2019) Shan Guan et al. Nature Nanotechnology
- The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome
- (2019) Alya A. Heirali et al. Journal of Cystic Fibrosis
- Novel cystamine-core dendrimer-formulation rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection by augmenting autophagy
- (2019) Janine Faraj et al. Expert Opinion on Drug Delivery
- Nanomedicine for Cystic Fibrosis
- (2019) Victor Ong et al. SLAS Technology
- Inhaled medications in cystic fibrosis beyond antibiotics
- (2019) Angela Sepe et al. MINERVA PEDIATRICA
- Emerging gene therapies for cystic fibrosis
- (2019) Kamran M. Miah et al. Expert Review of Respiratory Medicine
- Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
- (2019) Giulia Maule et al. Nature Communications
- Biopolymer nanogels improve antibacterial activity and safety profile of a novel lysine-based α-peptide/β-peptoid peptidomimetic
- (2018) Sylvia Natalie Kłodzińska et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa
- (2018) Hisham Al-Obaidi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Pseudomonas aeruginosa pyocyanin production reduced by quorum-sensing inhibiting nanocarriers
- (2018) Hoang D. Lu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- CFTR modulator theratyping: Current status, gaps and future directions
- (2018) John Paul Clancy et al. Journal of Cystic Fibrosis
- Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
- (2018) Ema Robinson et al. MOLECULAR THERAPY
- A highly specific SpCas9 variant is identified by in vivo screening in yeast
- (2018) Antonio Casini et al. NATURE BIOTECHNOLOGY
- Cystic fibrosis in the era of precision medicine
- (2018) Shruti M. Paranjape et al. Paediatric Respiratory Reviews
- Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre
- (2018) G. Spoletini et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Inhalation of peptide-loaded nanoparticles improves heart failure
- (2018) Michele Miragoli et al. Science Translational Medicine
- Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung
- (2018) Aristides D Tagalakis et al. THORAX
- In utero nanoparticle delivery for site-specific genome editing
- (2018) Adele S. Ricciardi et al. Nature Communications
- Electrochemically Synthesized Silver Nanoparticles Are Active Against Planktonic and Biofilm Cells of Pseudomonas aeruginosa and Other Cystic Fibrosis-Associated Bacterial Pathogens
- (2018) Arianna Pompilio et al. Frontiers in Microbiology
- Repurposing therapies for the personalised treatment of cystic fibrosis
- (2018) Antonella Tosco et al. Expert Opinion on Orphan Drugs
- Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions
- (2018) Julia Ernst et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Mucus-penetrating phage-displayed peptides for improved transport across a mucus-like model
- (2018) Jasmim Leal et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis
- (2018) Jingming Zhao et al. MICROBIAL PATHOGENESIS
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
- (2018) A. K. M. Ashiqul Haque et al. Scientific Reports
- Triplet CFTR modulators: future prospects for treatment of cystic fibrosis
- (2018) Nauman Chaudary Therapeutics and Clinical Risk Management
- Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier
- (2018) Caterina Cristallini et al. Materials Science & Engineering C-Materials for Biological Applications
- Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections
- (2017) Nazende Günday Türeli et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying
- (2017) Monica Agnoletti et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments
- (2017) William B. Guggino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Inhaled Antibiotic Therapy in Chronic Respiratory Diseases
- (2017) Diego Maselli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations
- (2017) Elizabeth Bielski et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cystic fibrosis: current therapeutic targets and future approaches
- (2017) Misbahuddin M. Rafeeq et al. Journal of Translational Medicine
- Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease
- (2017) L.A. Perry et al. Paediatric Respiratory Reviews
- Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis
- (2017) Scott Mackenzie Brockman et al. PLoS One
- Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data
- (2017) Kamal Hamed et al. Patient Preference and Adherence
- Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis
- (2017) Maria D. I. Manunta et al. Scientific Reports
- Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations
- (2016) Venkateshwar Mutyam et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
- (2016) A Tosco et al. CELL DEATH AND DIFFERENTIATION
- Disintegration of nano-embedded microparticles after deposition on mucus: A mechanistic study
- (2016) Christian A. Ruge et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications
- (2016) Mindaugas Rudokas et al. MEDICAL PRINCIPLES AND PRACTICE
- Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution
- (2016) Qian Zhong et al. MOLECULAR PHARMACEUTICS
- Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs
- (2016) Vittoria Di Mauro et al. Nanomedicine
- Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
- (2016) Anjali Y. Bhagirath et al. BMC Pulmonary Medicine
- CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
- (2016) Miquéias Lopes-Pacheco Frontiers in Pharmacology
- Progress in therapies for cystic fibrosis
- (2016) Kris De Boeck et al. Lancet Respiratory Medicine
- Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies
- (2016) Antoine Grillon et al. PLoS One
- Use of Inhaled Tobramycin in Cystic Fibrosis
- (2015) Michal Shteinberg et al. ADVANCES IN THERAPY
- Evaluation of tetrafunctional block copolymers as synthetic vectors for lung gene transfer
- (2015) Peggy Richard-Fiardo et al. BIOMATERIALS
- The roles of CRISPR–Cas systems in adaptive immunity and beyond
- (2015) Rodolphe Barrangou CURRENT OPINION IN IMMUNOLOGY
- Macrophage uptake of cylindrical microparticles investigated with correlative microscopy
- (2015) Clemens Tscheka et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy
- (2015) M. Moreno-Sastre et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nanotechnology approaches for inhalation treatment of lung diseases
- (2015) Andriy Kuzmov et al. JOURNAL OF CONTROLLED RELEASE
- Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients
- (2015) M. D. Amaral JOURNAL OF INTERNAL MEDICINE
- Inhalable nanoparticulate powders for respiratory delivery
- (2015) Priya Muralidharan et al. Nanomedicine-Nanotechnology Biology and Medicine
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium
- (2015) Nicole Ali McNeer et al. Nature Communications
- Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Eric W F W Alton et al. Lancet Respiratory Medicine
- Developments of mucus penetrating nanoparticles
- (2015) Min Liu et al. Asian Journal of Pharmaceutical Sciences
- Improving the efficacy of inhaled drugs in cystic fibrosis: Challenges and emerging drug delivery strategies
- (2014) Ivana d'Angelo et al. ADVANCED DRUG DELIVERY REVIEWS
- Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
- (2014) Daniela De Stefano et al. Autophagy
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Colistimethate Sodium Dry Powder for Inhalation: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis
- (2014) Daniel Conole et al. DRUGS
- Medical nanoparticles for next generation drug delivery to the lungs
- (2014) S. H. van Rijt et al. EUROPEAN RESPIRATORY JOURNAL
- Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies
- (2014) Pascale Fanen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
- (2014) Mukta Paranjpe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy
- (2014) Lisa M. Kaminskas et al. JOURNAL OF CONTROLLED RELEASE
- Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier
- (2014) Jung Soo Suk et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
- (2014) Kris De Boeck et al. Journal of Cystic Fibrosis
- European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
- (2014) Alan R. Smyth et al. Journal of Cystic Fibrosis
- Bioapplications of poly(amidoamine) (PAMAM) dendrimers in nanomedicine
- (2014) Negar Taghavi Pourianazar et al. JOURNAL OF NANOPARTICLE RESEARCH
- Poly(amidoamine) Dendrimer Nanocarriers and Their Aerosol Formulations for siRNA Delivery to the Lung Epithelium
- (2014) Denise S. Conti et al. MOLECULAR PHARMACEUTICS
- Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis
- (2014) Cedric Charrier et al. Orphanet Journal of Rare Diseases
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- A Decoy Oligonucleotide to NF-κB Delivered through Inhalable Particles Prevents LPS-Induced Rat Airway Inflammation
- (2013) Daniela De Stefano et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis
- (2013) Anna Caretti et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients
- (2013) Gerald Schwank et al. Cell Stem Cell
- Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
- (2013) Heino Stass et al. CLINICAL DRUG INVESTIGATION
- Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study
- (2013) Heino Stass et al. CLINICAL THERAPEUTICS
- Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review
- (2013) M. C. Gaspar et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art
- (2013) S. Weber et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Moving forward: cystic fibrosis gene therapy
- (2013) U. Griesenbach et al. HUMAN MOLECULAR GENETICS
- Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
- (2013) Sally-Ann Cryan et al. International Journal of Nanomedicine
- Nanotechnology approaches for inhalation treatment of fibrosis
- (2013) Ronak Savla et al. JOURNAL OF DRUG TARGETING
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides
- (2013) David C. Young et al. PEDIATRIC PULMONOLOGY
- Transport of Nanoparticles and Tobramycin-loaded Liposomes in Burkholderia cepacia Complex Biofilms
- (2013) Anne-Sophie Messiaen et al. PLoS One
- Inhalable DNase I microparticles engineered with biologically active excipients
- (2013) Rihab Osman et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Biodistribution of Amikacin Solid Lipid Nanoparticles after Pulmonary Delivery
- (2013) J. Varshosaz et al. Biomed Research International
- Solid lipid nanoparticles
- (2012) Wolfgang Mehnert et al. ADVANCED DRUG DELIVERY REVIEWS
- Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
- (2012) Laura M. Ensign et al. ADVANCED MATERIALS
- Cystic Fibrosis Transmembrane Conductance Regulator–Modifying Medications: The Future of Cystic Fibrosis Treatment
- (2012) Rebecca S Pettit ANNALS OF PHARMACOTHERAPY
- Progress in Gene and Cell Therapy for Cystic Fibrosis Lung Disease
- (2012) Uta Griesenbach et al. CURRENT PHARMACEUTICAL DESIGN
- Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
- (2012) Gerd Döring et al. Journal of Cystic Fibrosis
- A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis
- (2012) Kavi J. Littlewood et al. Journal of Cystic Fibrosis
- Interaction of Colistin and Colistin Methanesulfonate with Liposomes: Colloidal Aspects and Implications for Formulation
- (2012) Stephanie J. Wallace et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises
- (2012) Francesca Ungaro et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery
- (2012) Lauren Willis et al. LUNG
- Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
- (2012) Antje Schuster et al. THORAX
- Template-Assisted Polyelectrolyte Encapsulation of Nanoparticles into Dispersible, Hierarchically Nanostructured Microfibers
- (2011) Dorothee Kohler et al. ADVANCED MATERIALS
- Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis withPseudomonas aeruginosa
- (2011) David E. Geller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection
- (2011) Bruce C. Trapnell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis
- (2011) Niels Høiby BMC Medicine
- Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease
- (2011) Basma M Ibrahim et al. Expert Opinion on Drug Delivery
- Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
- (2011) David E. Geller et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- A strategy to deliver genes to cystic fibrosis lungs: A battle with environment
- (2011) Basma M. Ibrahim et al. JOURNAL OF CONTROLLED RELEASE
- Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers
- (2011) Francesca Ungaro et al. JOURNAL OF CONTROLLED RELEASE
- Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-κB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells
- (2011) Daniela De Stefano et al. JOURNAL OF GENE MEDICINE
- Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated withN-acetyl cysteine
- (2011) Jung Soo Suk et al. Nanomedicine
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics
- (2011) Manfred Ballmann et al. RESPIRATORY MEDICINE
- Chronic Macrolide Therapy in Inflammatory Airways Diseases
- (2010) Adam L. Friedlander et al. CHEST
- Development of Nanoparticles for Antimicrobial Drug Delivery
- (2010) L. Zhang et al. CURRENT MEDICINAL CHEMISTRY
- Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
- (2010) Anupa R. Menjoge et al. DRUG DISCOVERY TODAY
- Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation
- (2010) Tobias Lebhardt et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles
- (2010) Jaleh Varshosaz International Journal of Nanomedicine
- Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications
- (2010) J. Araújo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development and optimization of solid lipid nanoparticles of amikacin by central composite design
- (2010) Jaleh Varshosaz et al. JOURNAL OF LIPOSOME RESEARCH
- Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
- (2010) Lauren M Lim et al. PHARMACOTHERAPY
- Aqueous re-dispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy
- (2010) Katherine Kho et al. POWDER TECHNOLOGY
- New Antimicrobial Strategies in Cystic Fibrosis
- (2010) Mireille van Westreenen et al. PEDIATRIC DRUGS
- Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis
- (2010) Neeraj Vij et al. JOURNAL OF NANOBIOTECHNOLOGY
- Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection
- (2009) O. O. Okusanya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles
- (2009) Jung Soo Suk et al. BIOMATERIALS
- Recent advances in liposomal dry powder formulations: preparation and evaluation
- (2009) Ambikanandan Misra et al. Expert Opinion on Drug Delivery
- Liposomes as delivery systems for antibiotics
- (2009) Zuzanna Drulis-Kawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- An overview of liposome lyophilization and its future potential
- (2009) Chengjun Chen et al. JOURNAL OF CONTROLLED RELEASE
- Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
- (2009) Harry Heijerman et al. Journal of Cystic Fibrosis
- Cystic fibrosis
- (2009) Brian P O'Sullivan et al. LANCET
- Partial Correction of Cystic Fibrosis Defects with PLGA Nanoparticles Encapsulating Curcumin
- (2009) Malgorzata S. Cartiera et al. MOLECULAR PHARMACEUTICS
- Dendrimers and nanomedicine: multivalency in action
- (2009) Olivier Rolland et al. NEW JOURNAL OF CHEMISTRY
- Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis
- (2009) Misagh Alipour et al. PLoS One
- Aqueous re-dispersibility characterization of spray-dried hollow spherical silica nano-aggregates
- (2009) Katherine Kho et al. POWDER TECHNOLOGY
- Cystic Fibrosis: Pathogenesis and Future Treatment Strategies
- (2009) Felix A Ratjen Respiratory Care
- Aerosol Antibiotics in Cystic Fibrosis
- (2009) David E Geller Respiratory Care
- Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy
- (2008) Uta Griesenbach et al. ADVANCED DRUG DELIVERY REVIEWS
- Lipid nanoparticles for parenteral delivery of actives
- (2008) Medha D. Joshi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Inhaled nanoparticles—A current review
- (2008) Wei Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
- (2008) Jana Pardeike et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa
- (2008) M. Halwani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections
- (2008) P. Meers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Preparation and properties of inhalable nanocomposite particles: Effects of the temperature at a spray-dryer inlet upon the properties of particles
- (2007) Keishiro Tomoda et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Pharmacoscintigraphic and pharmacokinetic evaluation of tobramycin DPI formulations in cystic fibrosis patients
- (2007) Gabrielle Pilcer et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains
- (2007) Misagh Alipour et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery
- (2007) Dharmendra Jain et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
- Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway
- (2007) Sophie Moreau-Marquis et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation